Han, S., Pope, R., Li, S., Kishnani, P. S., Steet, R., & Koeberl, D. D. (2015). A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease. Mol Genet Metab.

Han, Sang-oh, Rand Pope, Songtao Li, Priya S. Kishnani, Richard Steet, and Dwight D. Koeberl. "A Beta-blocker, Propranolol, Decreases the Efficacy From Enzyme Replacement Therapy in Pompe Disease." Mol Genet Metab 2015.

Han, Sang-oh, et al. "A Beta-blocker, Propranolol, Decreases the Efficacy From Enzyme Replacement Therapy in Pompe Disease." Mol Genet Metab 2015.